Citation Impact
Citing Papers
Reconstitution of Human Telomerase Reverse Transcriptase Expression Rescues Colorectal Carcinoma Cells from In vitro Senescence: Evidence against Immortality as a Constitutive Trait of Tumor Cells
2005
Genetic and Functional Studies Implicate HIF1 α as a 14q Kidney Cancer Suppressor Gene
2011 StandoutNobel
Interaction of Hydroxylated Collagen IV with the von Hippel-Lindau Tumor Suppressor
2007 StandoutNobel
Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13
2006
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
2016 StandoutNatureNobel
Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition
2006 StandoutNobel
Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts
2009 StandoutNobel
Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma
2005 StandoutNobel
Enhancing extracellular vesicle cargo loading and functional delivery by engineering protein-lipid interactions
2024 StandoutNobel
New Technology and Health Care Costs — The Case of Robot-Assisted Surgery
2010 Standout
Acute kidney injury
2012 Standout
pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2
2007 StandoutNobel
The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
2008 StandoutNobel
The SIN3A histone deacetylase complex is required for a complete transcriptional response to hypoxia
2017 StandoutNobel
Molecular basis of the VHL hereditary cancer syndrome
2002 StandoutNobel
IAP-targeted therapies for cancer
2008
The metabolic syndrome
2010 Standout
Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.
1995
Head and neck cancer
2008 Standout
Molecular Aspects of Bladder Cancer
2002
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Renal-Cell Carcinoma
1996 Standout
Contrast Material-Induced Renal Failure in Patients with Diabetes Mellitus, Renal Insufficiency, or Both
1989 Standout
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
The mini-driver model of polygenic cancer evolution
2015 StandoutNobel
Urinary Biochemistry and Microscopy in Septic Acute Renal Failure: A Systematic Review
2006
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases
2010
HIF-1 Inhibits Mitochondrial Biogenesis and Cellular Respiration in VHL-Deficient Renal Cell Carcinoma by Repression of C-MYC Activity
2007 StandoutNobel
Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)–mediated induction of the long noncoding RNA NICI
2019 StandoutNobel
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
The metabolic syndrome
2005 Standout
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Bladder cancer
2016 Standout
Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo
2006 StandoutNobel
Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression
2012 StandoutNobel
Heterogeneous Effects of Direct Hypoxia Pathway Activation in Kidney Cancer
2015 StandoutNobel
Antigens for cancer immunotherapy
2008
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Epidemiology of carcinogen metabolism genes and risk of squamous cell carcinoma of the head and neck
2007
Cancer immunotherapy comes of age
2011 StandoutNature
Unexplained Spontaneous Regression and Alpha‐interferon as Treatment for Metastatic Renal Carcinoma
1989
Addicted to Death
2004
Hsp70 and CHIP Selectively Mediate Ubiquitination and Degradation of Hypoxia-inducible Factor (HIF)-1α but Not HIF-2α
2009 StandoutNobel
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
2002 StandoutNobel
A Randomized Trial of Radical Radiotherapy for the Management of pT1G3 NXM0 Transitional Cell Carcinoma of the Bladder
2007
Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
2008 StandoutNobel
Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus
2014
Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes
2003
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Head and Neck Cancer
2001 Standout
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
In Vitro Invasive Potential and Type IV Collagenolytic Activity of Human Renal Cell Carcinoma Cells Derived from Primary and Metastatic Lesions
1993
The adipoinsular axis: effects of leptin on pancreatic β-cells
2000
Phenotypic characterization of human colorectal cancer stem cells
2007 Standout
Stimulation of the Glucocorticoid-Induced TNF Receptor Family-Related Receptor on CD8 T Cells Induces Protective and High-Avidity T Cell Responses to Tumor-Specific Antigens
2010 StandoutNobel
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells.
1992
Systematic Review: Comparative Effectiveness and Harms of Treatments for Clinically Localized Prostate Cancer
2008
Urinary Biomarkers for Diagnosis of Bladder Cancer
2015
Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma.
1997
Development of a therapeutic monoclonal antibody that targets secreted fatty acid–binding protein aP2 to treat type 2 diabetes
2015
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Characterisation of adipocyte‐derived extracellular vesicle subtypes identifies distinct protein and lipid signatures for large and small extracellular vesicles
2017
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Growth regulation of human renal carcinoma cells: role of transforming growth factor alpha.
1992
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
The von Hippel-Lindau Tumor Suppressor Gene Inhibits Hepatocyte Growth Factor/Scatter Factor-Induced Invasion and Branching Morphogenesis in Renal Carcinoma Cells
1999 StandoutNobel
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
2016 StandoutNobel
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Leptin Effects on Pancreatic β-Cell Gene Expression and Function
2004
VHL Induces Renal Cell Differentiation and Growth Arrest through Integration of Cell-Cell and Cell-Extracellular Matrix Signaling
2001
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
Nephrotoxicity from angiographic contrast material
1982
Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
1998
Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids.
1999
Works of Thomas Ebert being referenced
Biological potentials of interferons relevance in the systemic treatment of superficial bladder carcinoma
1986
Simultaneous Diagnosis of a Metanephric Adenoma and a Clear Cell Carcinoma of the Contralateral Kidney
2001
Immunocytology in the assessment of patients with asymptomatic hematuria
2007
Interaction of GLP-I and Leptin at Rat Pancreatic B-Cells: Effects on Insulin Secretion and Signal Transduction
1997
Rolle der Immunzytologie in der Abklärung von Patienten mit schmerzloser Makrohämaturie
2010
Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies
1997
Immunocytology in the assessment of patients with painless gross haematuria
2007
XIAP expression is an independent prognostic marker in clear-cell renal carcinomas1 1The results of the study are part of the PhD thesis of E. Caliskan.
2004
Immunocytology in the Assessment of Patients with Asymptomatic Microhaematuria
2006
Adipocyte fatty acid-binding protein is released from adipocytes by a non-conventional mechanism
2013
Untersuchungen zur Rolle der Immunzytologie in der Abklärung von Patienten mit asymptomatischer Mikrohämaturie
2007
Kidney-derived cell lines.
1989
Lowered amounts of the tissue-specific transcription factor LFB1 (HNF1) correlate with decreased levels of glutathione S-transferase alpha messenger RNA in human renal cell carcinoma.
1994
Rapid Radioimmunoassay for Diagnosing Acute Tubular Necrosis
1980
Circulating adipocyte fatty acid-binding protein induces insulin resistance in micein vivo
2015
Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis
2009
Establishment and characterization of human renal cancer and normal kidney cell lines.
1990
Major Histocompatibility Complex Class I and Class II Expression in Renal Cell Carcinoma and Modulation by Interferon Gamma
1996
IMPLICATION OF RETINOIC ACID RECEPTOR-BETA IN RENAL-CELL CARCINOMA
1995
p53 Immunohistochemistry as a Prognostic Marker in Bladder Cancer
2000
Loss of function of the tissue specific transcription factor HNF1 alpha in renal cell carcinoma and clinical prognosis.
1999
Loss of HNF1? function in human renal cell carcinoma: Frequent mutations in theVHL gene but not theHNF1? gene
1999